Ceftaroline fosamil - Injection Products
Recognized Interpretive Criteria
Exceptions to the recognized standard of CLSI M100
|
|
Minimum Inhibitory |
Disk Diffusion |
||||
|---|---|---|---|---|---|---|
|
Pathogen |
S |
I |
R |
S |
I |
R |
|
Enterobacterales |
M100 standard is recognized |
|||||
|
Staphylococcus aureus (including MRSA) |
≤1 |
2 |
≥4 |
≥24 |
21-23 |
≤20 |
|
Haemophilus influenzae and parainfluenzae |
M100 standard is recognized |
|||||
|
Streptococcus pneumoniae |
M100 standard is recognized |
|||||
|
Streptococcus spp β- Hemolytic Group |
M100 standard is recognized |
|||||
S = Susceptible; I = Intermediate; R = Resistant
STIC are based on a dosing regimen of 600 mg every 12 h.